Lawhorne LW, Ouslander JG, Parmelee PA, Resnick B, Calabrese B. Urinary incontinence: a neglected geriatric syndrome in nursing facilities. J Am Med Dir Assoc 2008; 9: 29-35.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78.
Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, et al. Benign prostatic hyperplasia. Nat Rev Dis Primers 2016; 2: 16031.
Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci 2008; 9: 453-66.
Cameron AP, Heidelbaugh JJ, Jimbo M. Diagnosis and office-based treatment of urinary incontinence in adults. Part one: diagnosis and testing. Ther Adv Urol 2013; 5: 181-7.
Jung HB, Kim HJ, Cho ST. A current perspective on geriatric lower urinary tract dysfunction. Korean J Urol 2015; 56: 266-75.
Oh SJ, Park WH, Park CH, Paick JS, Seo JT, Lee YS, et al. Prevalence of urinary incontinence and incontinence-related quality of life in Korean women:a population-based study. J Korean Cont Soc 2003; 7: 73-80.
Khandelwal C, Kistler C. Diagnosis of urinary incontinence. Am Fam Physician 2013; 87: 543-50.
Bradley CS, Rahn DD, Nygaard IE, Barber MD, Nager CW, Kenton KS, et al. The questionnaire for urinary incontinence diagnosis (QUID): validity and responsiveness to change in women undergoing non-surgical therapies for treatment of stress predominant urinary incontinence. Neurourol Urodyn 2010; 29: 727-34.
The Korean Prostate Society. Clinical guidelines of benign prostatic hyperplasia. Seoul: Medrang; 2010.
Newman DK, Cardozo L, Sievert KD. Preventing urinary incontinence in women. Curr Opin Obstet Gynecol 2013; 25: 388-94.
Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. Urinary incontinence in women: a review. JAMA 2017; 318: 1592-604.
Cameron AP, Jimbo M, Heidelbaugh JJ. Diagnosis and office-based treatment of urinary incontinence in adults. Part two: treatment. Ther Adv Urol 2013; 5: 189-200.
European Association of Urology. Guidelines for urinary incontinence. Arnhem: European Association of Urology; 2018.
Hersh L, Salzman B. Clinical management of urinary incontinence in women. Am Fam Physician 2013; 87: 634-40.
Malhotra B, Gandelman K, Sachse R, Wood N, Michel MC. The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine. Curr Med Chem 2009; 16:4481-9.
Kwon HA, Kim HJ, Seo YJ, OH SJ, Lee KC, Lee SH, et al. Clinical guideline on overactive bladder. 3rd ed. Seoul: Korean continence society; 2016.
Kim HJ, Kim TH, Moon KH, Yeo JK, Lee KC, Lee SH, et al. Clinical guideline on overactive bladder. 2nd ed. Seoul: Korean continence society; 2011.
Wood LN, Anger JT. Urinary incontinence in women. BMJ 2014; 349:g4531.
Choi JB. Urinary incontinence in women. Korean J Fam Med 2010; 31: 66171.